Management of Barrett's Esophagus: Practice-Oriented Answers to Clinical Questions.

Barrett diagnosis esophagus therapy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
23 Mar 2023
Historique:
received: 08 02 2023
revised: 15 03 2023
accepted: 18 03 2023
medline: 14 4 2023
entrez: 13 4 2023
pubmed: 14 4 2023
Statut: epublish

Résumé

Barrett's esophagus is the most important complication of gastro-esophageal reflux disease and the only known precursor of esophageal adenocarcinoma. The diagnosis and treatment of Barrett's esophagus are clinically challenging as it requires a high level of knowledge and competence in upper gastrointestinal endoscopy. For instance, endoscopists should know when and how to perform biopsies when Barrett's esophagus is suspected. Furthermore, the correct identification and treatment of dysplastic Barrett's esophagus is crucial to prevent progression to cancer as well as it is the endoscopic surveillance of treated patients. Herein, we report practice-oriented answers to clinical questions that clinicians should be aware of when approaching patients with Barrett's esophagus.

Identifiants

pubmed: 37046590
pii: cancers15071928
doi: 10.3390/cancers15071928
pmc: PMC10093467
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Am J Gastroenterol. 2006 Aug;101(8):1900-20; quiz 1943
pubmed: 16928254
Dig Dis Sci. 2021 Sep;66(9):2888-2896
pubmed: 32984930
Gastrointest Endosc. 2021 Jul;94(1):14-21
pubmed: 33373645
Endoscopy. 2020 Jun;52(6):491-497
pubmed: 32289855
Gastrointest Endosc. 2008 Apr;67(4):604-9
pubmed: 18155214
Gastroenterology. 2017 Apr;152(5):987-992
pubmed: 27988383
Am J Gastroenterol. 2016 Jan;111(1):30-50; quiz 51
pubmed: 26526079
Gastrointest Endosc. 2018 Apr;87(4):907-931.e9
pubmed: 29397943
J Gastroenterol Hepatol. 2016 Sep;31(9):1527-38
pubmed: 26840528
Cancer Epidemiol Biomarkers Prev. 2020 Nov;29(11):2109-2118
pubmed: 32855267
Dig Dis Sci. 2019 May;64(5):1089-1097
pubmed: 30911864
Clin Gastroenterol Hepatol. 2009 Jul;7(7):736-42; quiz 710
pubmed: 19268726
Am J Gastroenterol. 2014 Feb;109(2):178-82
pubmed: 24343550
Ann Surg. 2021 Dec 1;274(6):e535-e540
pubmed: 31800492
Gut. 2013 Jan;62(1):15-21
pubmed: 22315471
Gut. 2021 Mar;70(3):456-463
pubmed: 32732370
Expert Rev Gastroenterol Hepatol. 2020 Jun;14(6):425-433
pubmed: 32441160
Gastrointest Endosc. 2019 Sep;90(3):335-359.e2
pubmed: 31439127
Clin Gastroenterol Hepatol. 2018 Jul;16(7):1046-1055.e8
pubmed: 29199147
Am J Gastroenterol. 2022 Jan 1;117(1):27-56
pubmed: 34807007
Clin Gastroenterol Hepatol. 2014 Feb;12(2):239-45
pubmed: 23988686
Gastroenterology. 2006 Nov;131(5):1392-9
pubmed: 17101315
Endoscopy. 2017 Feb;49(2):191-198
pubmed: 28122386
Gastrointest Endosc. 2016 Jan;83(1):57-67.e1
pubmed: 26371851
Gastroenterology. 2021 Aug;161(2):487-494.e4
pubmed: 33974935
Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2486-2494
pubmed: 33093162

Auteurs

Rocco Maurizio Zagari (RM)

Department of Digestive Diseases, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.
Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.

Veronica Iascone (V)

Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.

Lorenzo Fuccio (L)

Department of Digestive Diseases, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.
Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.

Alba Panarese (A)

Division of Gastroenterology and Digestive Endoscopy, Department of Medical Sciences, Central Hospital, Azienda Ospedaliera, 74100 Taranto, Italy.

Leonardo Frazzoni (L)

Department of Digestive Diseases, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.

Classifications MeSH